| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RAF1 CDKL2 ADCK1 OBSCN STK32C CDKL1 CDKL5 TGFBR3 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 2.04e-06 | 446 | 135 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 TGFBR3 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 3.05e-06 | 600 | 135 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | protein serine kinase activity | RAF1 CDKL2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 6.77e-06 | 363 | 135 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | collagen binding | 1.83e-05 | 81 | 135 | 6 | GO:0005518 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 TGFBR3 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 2.44e-05 | 709 | 135 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | protein tyrosine kinase collagen receptor activity | 4.54e-05 | 2 | 135 | 2 | GO:0038062 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 4.78e-05 | 30 | 135 | 4 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 4.78e-05 | 30 | 135 | 4 | GO:0097472 | |
| GeneOntologyMolecularFunction | kinase activity | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 TGFBR3 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 5.97e-05 | 764 | 135 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 TGFBR3 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 6.05e-04 | 938 | 135 | 16 | GO:0016772 |
| GeneOntologyMolecularFunction | collagen receptor activity | 6.69e-04 | 6 | 135 | 2 | GO:0038064 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.45e-06 | 84 | 137 | 7 | GO:1903053 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | DPP4 DDR1 ST7 DDR2 LAMC1 TGFBR3 ADAMTSL5 AEBP1 TLL1 WNT3A NID1 MMP2 | 8.35e-06 | 377 | 137 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | DPP4 DDR1 ST7 DDR2 LAMC1 TGFBR3 ADAMTSL5 AEBP1 TLL1 WNT3A NID1 MMP2 | 8.57e-06 | 378 | 137 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | DPP4 DDR1 ST7 DDR2 LAMC1 TGFBR3 ADAMTSL5 AEBP1 TLL1 WNT3A NID1 MMP2 | 8.80e-06 | 379 | 137 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | Schwann cell development | 1.47e-05 | 47 | 137 | 5 | GO:0014044 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin maintenance | 2.34e-05 | 9 | 137 | 3 | GO:0032287 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 2.34e-05 | 9 | 137 | 3 | GO:0140212 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 3.20e-05 | 55 | 137 | 5 | GO:0014037 | |
| GeneOntologyBiologicalProcess | developmental growth | DDR1 ERCC6 DSCAM KIF26B RBM10 TRPC5 DDR2 SPG11 CDKL5 TGFBR3 LIMK1 DHCR7 WNT3A LRP4 AKT1 KDM2A MAPK1 PLEC | 3.43e-05 | 911 | 137 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 1.43e-04 | 75 | 137 | 5 | GO:0022617 | |
| GeneOntologyBiologicalProcess | growth | PAPPA2 DDR1 ERCC6 DSCAM KIF26B RBM10 TRPC5 DDR2 SPG11 ST7L CDKL5 TGFBR3 LIMK1 DHCR7 WNT3A LRP4 AKT1 KDM2A MAPK1 PLEC | 1.91e-04 | 1235 | 137 | 20 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 1.95e-04 | 238 | 137 | 8 | GO:0048639 | |
| GeneOntologyBiologicalProcess | myelin maintenance | 2.17e-04 | 18 | 137 | 3 | GO:0043217 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 2.34e-04 | 130 | 137 | 6 | GO:1905477 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 2.60e-04 | 4 | 137 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 2.60e-04 | 4 | 137 | 2 | GO:0140213 | |
| Domain | Kinase-like_dom | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN WDR81 STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 1.75e-06 | 542 | 134 | 16 | IPR011009 |
| Domain | Prot_kinase_dom | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 2.36e-06 | 489 | 134 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | RAF1 DDR1 CDKL2 ADCK1 DDR2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 2.61e-06 | 493 | 134 | 15 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | RAF1 DDR1 CDKL2 ADCK1 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 5.59e-06 | 459 | 134 | 14 | PS00107 |
| Domain | Ser/Thr_kinase_AS | RAF1 CDKL2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 1.03e-05 | 357 | 134 | 12 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | RAF1 CDKL2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 1.18e-05 | 362 | 134 | 12 | PS00108 |
| Domain | Pkinase | RAF1 CDKL2 OBSCN STK32C CDKL1 CDKL5 LIMK1 BUB1B AKT1 AKT2 CDK11B MAPK1 | 1.97e-05 | 381 | 134 | 12 | PF00069 |
| Domain | ST7 | 5.11e-05 | 2 | 134 | 2 | PF04184 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 5.11e-05 | 2 | 134 | 2 | IPR013037 | |
| Domain | - | 5.11e-05 | 2 | 134 | 2 | 2.60.40.1150 | |
| Domain | ST7 | 5.11e-05 | 2 | 134 | 2 | IPR007311 | |
| Domain | DDR1/DDR2 | 5.11e-05 | 2 | 134 | 2 | IPR029553 | |
| Domain | AP_complex_bsu_1_2_4 | 1.53e-04 | 3 | 134 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.53e-04 | 3 | 134 | 2 | PF09066 | |
| Domain | - | 1.79e-04 | 73 | 134 | 5 | 2.60.120.260 | |
| Domain | S_TKc | 2.69e-04 | 359 | 134 | 10 | SM00220 | |
| Domain | - | 3.04e-04 | 4 | 134 | 2 | 3.40.1280.10 | |
| Domain | B2-adapt-app_C | 3.04e-04 | 4 | 134 | 2 | SM01020 | |
| Domain | tRNA_m1G_MTases_N | 3.04e-04 | 4 | 134 | 2 | IPR029026 | |
| Domain | B-adaptin_app_sub_C | 3.04e-04 | 4 | 134 | 2 | IPR015151 | |
| Domain | Protein_kinase_ATP_BS | 4.12e-04 | 379 | 134 | 10 | IPR017441 | |
| Domain | FA58C | 4.37e-04 | 21 | 134 | 3 | SM00231 | |
| Domain | FA58C_3 | 4.37e-04 | 21 | 134 | 3 | PS50022 | |
| Domain | FA58C_1 | 4.37e-04 | 21 | 134 | 3 | PS01285 | |
| Domain | FA58C_2 | 4.37e-04 | 21 | 134 | 3 | PS01286 | |
| Domain | GRAM | 5.03e-04 | 22 | 134 | 3 | PF02893 | |
| Domain | GRAM | 5.03e-04 | 22 | 134 | 3 | IPR004182 | |
| Domain | FerI | 5.04e-04 | 5 | 134 | 2 | SM01202 | |
| Domain | FerB | 5.04e-04 | 5 | 134 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 5.04e-04 | 5 | 134 | 2 | IPR012561 | |
| Domain | AP_beta | 5.04e-04 | 5 | 134 | 2 | IPR026739 | |
| Domain | Ferlin_C | 5.04e-04 | 5 | 134 | 2 | PF16165 | |
| Domain | Ferlin_C | 5.04e-04 | 5 | 134 | 2 | IPR032362 | |
| Domain | FerIin_dom | 5.04e-04 | 5 | 134 | 2 | IPR012968 | |
| Domain | FerI | 5.04e-04 | 5 | 134 | 2 | PF08151 | |
| Domain | FerB | 5.04e-04 | 5 | 134 | 2 | PF08150 | |
| Domain | Galactose-bd-like | 5.81e-04 | 94 | 134 | 5 | IPR008979 | |
| Domain | F5_F8_type_C | 6.55e-04 | 24 | 134 | 3 | PF00754 | |
| Domain | FA58C | 6.55e-04 | 24 | 134 | 3 | IPR000421 | |
| Domain | Alpha/beta_knot_MTases | 7.52e-04 | 6 | 134 | 2 | IPR029028 | |
| Domain | Beta2_adaptin/TBP_C_dom | 7.52e-04 | 6 | 134 | 2 | IPR012295 | |
| Domain | - | 7.52e-04 | 6 | 134 | 2 | 3.30.310.10 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.39e-03 | 8 | 134 | 2 | IPR009028 | |
| Domain | LAMININ_IVA | 1.39e-03 | 8 | 134 | 2 | PS51115 | |
| Domain | Laminin_B | 1.39e-03 | 8 | 134 | 2 | PF00052 | |
| Domain | LamB | 1.39e-03 | 8 | 134 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.39e-03 | 8 | 134 | 2 | IPR000034 | |
| Domain | Alpha_adaptinC2 | 1.78e-03 | 9 | 134 | 2 | PF02883 | |
| Domain | BEACH | 1.78e-03 | 9 | 134 | 2 | PS50197 | |
| Domain | Beach | 1.78e-03 | 9 | 134 | 2 | PF02138 | |
| Domain | - | 1.78e-03 | 9 | 134 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.78e-03 | 9 | 134 | 2 | SM01026 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.78e-03 | 9 | 134 | 2 | IPR008152 | |
| Domain | BEACH_dom | 1.78e-03 | 9 | 134 | 2 | IPR000409 | |
| Domain | Alpha_adaptinC2 | 1.78e-03 | 9 | 134 | 2 | SM00809 | |
| Domain | EGF-like_dom | 2.15e-03 | 249 | 134 | 7 | IPR000742 | |
| Domain | EGF_1 | 2.46e-03 | 255 | 134 | 7 | PS00022 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.69e-03 | 11 | 134 | 2 | IPR002011 | |
| Domain | EGF-like_CS | 2.80e-03 | 261 | 134 | 7 | IPR013032 | |
| Domain | EGF_2 | 3.05e-03 | 265 | 134 | 7 | PS01186 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.22e-03 | 12 | 134 | 2 | IPR013041 | |
| Domain | RECEPTOR_TYR_KIN_II | 3.22e-03 | 12 | 134 | 2 | PS00239 | |
| Domain | CarboxyPept_regulatory_dom | 3.78e-03 | 13 | 134 | 2 | IPR014766 | |
| Domain | - | 3.78e-03 | 13 | 134 | 2 | 2.60.40.1120 | |
| Domain | Acyl_CoA_acyltransferase | 4.11e-03 | 45 | 134 | 3 | IPR016181 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.38e-03 | 46 | 134 | 3 | IPR011042 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | Ldl_recept_b | 4.39e-03 | 14 | 134 | 2 | PF00058 | |
| Domain | LDLRB | 4.39e-03 | 14 | 134 | 2 | PS51120 | |
| Domain | AAA_5 | 4.39e-03 | 14 | 134 | 2 | PF07728 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.05e-03 | 15 | 134 | 2 | IPR002553 | |
| Domain | LY | 5.05e-03 | 15 | 134 | 2 | SM00135 | |
| Domain | Adaptin_N | 5.05e-03 | 15 | 134 | 2 | PF01602 | |
| Domain | LDLR_classB_rpt | 5.05e-03 | 15 | 134 | 2 | IPR000033 | |
| Domain | Growth_fac_rcpt_ | 5.37e-03 | 156 | 134 | 5 | IPR009030 | |
| Domain | GRAM | 5.74e-03 | 16 | 134 | 2 | SM00568 | |
| Domain | Laminin_N | 5.74e-03 | 16 | 134 | 2 | IPR008211 | |
| Domain | LamNT | 5.74e-03 | 16 | 134 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 5.74e-03 | 16 | 134 | 2 | PS51117 | |
| Domain | Laminin_N | 5.74e-03 | 16 | 134 | 2 | PF00055 | |
| Domain | CarboxyPept-like_regulatory | 6.48e-03 | 17 | 134 | 2 | IPR008969 | |
| Domain | EGF | 7.03e-03 | 235 | 134 | 6 | SM00181 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | DDR1 CAPN1 DDR2 LAMC1 LAMC3 SH3PXD2A TLL1 LRP4 NID1 MMP2 PLEC | 5.39e-06 | 300 | 95 | 11 | M610 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.42e-05 | 9 | 95 | 3 | MM15666 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 3.02e-05 | 27 | 95 | 4 | M1718 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 3.04e-05 | 54 | 95 | 5 | M42568 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 3.97e-05 | 57 | 95 | 5 | M19888 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 4.04e-05 | 29 | 95 | 4 | M39516 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 9.32e-05 | 68 | 95 | 5 | M48322 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.06e-04 | 161 | 95 | 7 | M39770 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.33e-04 | 39 | 95 | 4 | M39905 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 1.50e-04 | 119 | 95 | 6 | M48309 | |
| Pathway | WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING | 1.78e-04 | 42 | 95 | 4 | M39452 | |
| Pathway | SA_PTEN_PATHWAY | 1.88e-04 | 17 | 95 | 3 | M12771 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 2.25e-04 | 18 | 95 | 3 | MM1482 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 2.54e-04 | 46 | 95 | 4 | M8626 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 2.66e-04 | 19 | 95 | 3 | M39370 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 2.66e-04 | 19 | 95 | 3 | MM1361 | |
| Pathway | BIOCARTA_MAL_PATHWAY | 2.66e-04 | 19 | 95 | 3 | M10547 | |
| Pathway | BIOCARTA_CCR3_PATHWAY | 2.66e-04 | 19 | 95 | 3 | M9152 | |
| Pathway | WP_FOCAL_ADHESION | 2.67e-04 | 187 | 95 | 7 | MM15913 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.40e-04 | 325 | 95 | 9 | M12868 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.52e-04 | 50 | 95 | 4 | M48087 | |
| Pathway | WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN | 3.61e-04 | 21 | 95 | 3 | M48342 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 3.80e-04 | 51 | 95 | 4 | M7955 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 4.09e-04 | 52 | 95 | 4 | M19877 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 4.16e-04 | 22 | 95 | 3 | MM1438 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 4.43e-04 | 5 | 95 | 2 | M48999 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 4.71e-04 | 96 | 95 | 5 | M16121 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 4.73e-04 | 54 | 95 | 4 | M19818 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 4.76e-04 | 23 | 95 | 3 | MM15952 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 4.76e-04 | 23 | 95 | 3 | M19613 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 5.07e-04 | 55 | 95 | 4 | M39685 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 5.42e-04 | 24 | 95 | 3 | M27952 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 5.43e-04 | 99 | 95 | 5 | MM15905 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 6.12e-04 | 25 | 95 | 3 | M39794 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 6.12e-04 | 25 | 95 | 3 | M39384 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 6.12e-04 | 25 | 95 | 3 | M39574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY | 6.12e-04 | 25 | 95 | 3 | MM17240 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 6.22e-04 | 102 | 95 | 5 | MM15830 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 6.22e-04 | 102 | 95 | 5 | M39577 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.62e-04 | 6 | 95 | 2 | M27559 | |
| Pathway | REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY | 6.62e-04 | 6 | 95 | 2 | MM15273 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 6.62e-04 | 6 | 95 | 2 | M47523 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 6.63e-04 | 59 | 95 | 4 | M39750 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.63e-04 | 59 | 95 | 4 | M27218 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 6.79e-04 | 104 | 95 | 5 | M39625 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 6.89e-04 | 26 | 95 | 3 | M14512 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 6.89e-04 | 26 | 95 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 6.89e-04 | 26 | 95 | 3 | MM15896 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 6.89e-04 | 26 | 95 | 3 | M48092 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 6.89e-04 | 26 | 95 | 3 | MM1423 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.36e-04 | 439 | 95 | 10 | M42563 | |
| Pathway | WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING | 7.71e-04 | 27 | 95 | 3 | M39609 | |
| Pathway | KEGG_COLORECTAL_CANCER | 8.01e-04 | 62 | 95 | 4 | M14631 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 8.51e-04 | 63 | 95 | 4 | M39623 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 9.23e-04 | 7 | 95 | 2 | MM17070 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 9.23e-04 | 7 | 95 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 9.23e-04 | 7 | 95 | 2 | M47790 | |
| Pathway | KEGG_GLIOMA | 9.57e-04 | 65 | 95 | 4 | M1835 | |
| Pathway | WP_AGERAGE_PATHWAY | 1.01e-03 | 66 | 95 | 4 | M39420 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.05e-03 | 30 | 95 | 3 | M27216 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 1.11e-03 | 116 | 95 | 5 | MM15863 | |
| Pathway | WP_MELANOMA | 1.13e-03 | 68 | 95 | 4 | M39811 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 1.16e-03 | 117 | 95 | 5 | M39530 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 1.16e-03 | 31 | 95 | 3 | M213 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47399 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 1.23e-03 | 8 | 95 | 2 | M48010 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47715 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.23e-03 | 8 | 95 | 2 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.23e-03 | 8 | 95 | 2 | M47498 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.26e-03 | 70 | 95 | 4 | M13266 | |
| Pathway | KEGG_PANCREATIC_CANCER | 1.26e-03 | 70 | 95 | 4 | M9726 | |
| Pathway | WP_IL17_SIGNALING | 1.28e-03 | 32 | 95 | 3 | M39560 | |
| Pathway | WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS | 1.28e-03 | 32 | 95 | 3 | M39893 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.33e-03 | 71 | 95 | 4 | MM15590 | |
| Pathway | KEGG_MELANOMA | 1.33e-03 | 71 | 95 | 4 | M15798 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 1.40e-03 | 33 | 95 | 3 | M39745 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.40e-03 | 33 | 95 | 3 | M39503 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.40e-03 | 33 | 95 | 3 | MM1426 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.40e-03 | 72 | 95 | 4 | M39738 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 1.48e-03 | 73 | 95 | 4 | M39758 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 1.48e-03 | 73 | 95 | 4 | M321 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.52e-03 | 34 | 95 | 3 | M3342 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47481 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47972 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.63e-03 | 75 | 95 | 4 | M27874 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.63e-03 | 75 | 95 | 4 | M5436 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.66e-03 | 35 | 95 | 3 | M249 | |
| Pathway | KEGG_PRION_DISEASES | 1.66e-03 | 35 | 95 | 3 | M13036 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 19887570 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CALCOCO2 RAF1 DDR1 DPY19L1 ADCK1 DDR2 LIMK1 AP1B1 AP2B1 SH3PXD2A BUB1B AKT1 AKT2 EIF3B CDK11B MAPK1 PLEC | 1.36e-07 | 910 | 138 | 17 | 36736316 |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.83e-07 | 211 | 138 | 9 | 24097068 | |
| Pubmed | 2.30e-07 | 14 | 138 | 4 | 12773577 | ||
| Pubmed | RAF1 CAPN1 CPD AP1B1 AP2B1 DNAH17 MTMR2 AKT1 KDM2A AKT2 CDK11B MMP2 MAPK1 KLHL8 DNAH11 | 2.35e-07 | 730 | 138 | 15 | 34857952 | |
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 15499549 | ||
| Pubmed | RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib. | 2.44e-07 | 4 | 138 | 3 | 23923067 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAF1 RBM15 ZBTB16 NAA15 KIF26B WWP2 LAMC1 PARD3B STK32C WDR59 LIMK1 MDN1 SH3PXD2A BUB1B PLEC DOP1A | 3.49e-07 | 861 | 138 | 16 | 36931259 |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 10983986 | ||
| Pubmed | Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. | 6.08e-07 | 5 | 138 | 3 | 19816934 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 21335558 | ||
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 18063683 | ||
| Pubmed | CALCOCO2 PAPPA2 ZBTB16 ERCC6 GLRX3 WWP2 LAMC1 AP1B1 YLPM1 NID1 KDM2A PLEC SDK1 | 7.35e-07 | 591 | 138 | 13 | 15231748 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 25733533 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 14749824 | ||
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 24623414 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 1.21e-06 | 6 | 138 | 3 | 11707444 | |
| Pubmed | Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. | 2.11e-06 | 7 | 138 | 3 | 28689659 | |
| Pubmed | Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. | 3.37e-06 | 8 | 138 | 3 | 20816796 | |
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 19058874 | ||
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 24469921 | ||
| Pubmed | HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. | 3.37e-06 | 8 | 138 | 3 | 22904195 | |
| Pubmed | PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung. | 5.05e-06 | 9 | 138 | 3 | 15695173 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DHX36 CACNA2D1 DPY19L1 GLRX3 DNAJC18 LAMC1 LAMC3 CPD MYORG TLL1 DHCR7 JMJD8 LRP4 NID1 MMP2 BACE2 CDH13 | 5.95e-06 | 1201 | 138 | 17 | 35696571 |
| Pubmed | Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice. | 7.19e-06 | 10 | 138 | 3 | 26435415 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPOUT1 ATP13A1 OBSCN SPATA20 LAMC3 STK32C WDR59 MYORG MDN1 ADAMTSL5 KLHL36 LRP4 PCNX1 AKT1 AKT2 PLEC | 8.61e-06 | 1105 | 138 | 16 | 35748872 |
| Pubmed | 9.25e-06 | 257 | 138 | 8 | 16335952 | ||
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 11435472 | ||
| Pubmed | Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. | 9.85e-06 | 11 | 138 | 3 | 21423810 | |
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 21084308 | ||
| Pubmed | Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. | 9.85e-06 | 11 | 138 | 3 | 23742646 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27878243 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25265753 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27699769 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23125486 | ||
| Pubmed | Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. | 1.56e-05 | 2 | 138 | 2 | 31252679 | |
| Pubmed | Activation of Erk1/2 and Akt following unilateral ureteral obstruction. | 1.56e-05 | 2 | 138 | 2 | 18449171 | |
| Pubmed | Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. | 1.56e-05 | 2 | 138 | 2 | 19622728 | |
| Pubmed | Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. | 1.56e-05 | 2 | 138 | 2 | 28271235 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28863860 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17019809 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17113033 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 10958679 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33377281 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12930721 | ||
| Pubmed | Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. | 1.56e-05 | 2 | 138 | 2 | 9620559 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11861503 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12808085 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15010337 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 36229454 | ||
| Pubmed | Akt2 regulates cardiac metabolism and cardiomyocyte survival. | 1.56e-05 | 2 | 138 | 2 | 16950770 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20332370 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 3037531 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 32078465 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23076793 | ||
| Pubmed | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. | 1.56e-05 | 2 | 138 | 2 | 19110052 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23919516 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17804734 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27408773 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17141631 | ||
| Pubmed | PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement. | 1.56e-05 | 2 | 138 | 2 | 31781306 | |
| Pubmed | Laminin gamma3 chain binds to nidogen and is located in murine basement membranes. | 1.56e-05 | 2 | 138 | 2 | 15824114 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23674478 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30692211 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19900459 | ||
| Pubmed | Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas. | 1.56e-05 | 2 | 138 | 2 | 24723326 | |
| Pubmed | Distinct actions of akt1 on skeletal architecture and function. | 1.56e-05 | 2 | 138 | 2 | 24663486 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16611738 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19491266 | ||
| Pubmed | Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | 1.56e-05 | 2 | 138 | 2 | 17609365 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17825284 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15994435 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31847370 | ||
| Pubmed | Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. | 1.56e-05 | 2 | 138 | 2 | 26654940 | |
| Pubmed | Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface. | 1.56e-05 | 2 | 138 | 2 | 12931195 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16923802 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24361528 | ||
| Pubmed | Role of AMPK and Akt in triple negative breast cancer lung colonization. | 1.56e-05 | 2 | 138 | 2 | 33839456 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21432781 | ||
| Pubmed | Molecular alterations in AKT and its protein activation in human lung carcinomas. | 1.56e-05 | 2 | 138 | 2 | 22748472 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17045205 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12935821 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25387007 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14764702 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17299390 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31671832 | ||
| Pubmed | PKB signaling and atrogene expression in skeletal muscle of aged mice. | 1.56e-05 | 2 | 138 | 2 | 21551011 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24769357 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23567263 | ||
| Pubmed | Complex roles of discoidin domain receptor tyrosine kinases in cancer. | 1.56e-05 | 2 | 138 | 2 | 33634432 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 7774938 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24018687 | ||
| Pubmed | Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. | 1.56e-05 | 2 | 138 | 2 | 16365168 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21881167 | ||
| Pubmed | Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma. | 1.56e-05 | 2 | 138 | 2 | 15102693 | |
| Pubmed | AKT1 and AKT2 induce distinct phosphorylation patterns in HL-1 cardiac myocytes. | 1.56e-05 | 2 | 138 | 2 | 25162660 | |
| Pubmed | Molecular cloning and characterization of mouse St7r (St7-like, St7l). | 1.56e-05 | 2 | 138 | 2 | 12060862 | |
| Pubmed | The Akt1 isoform is an essential mediator of ischaemic preconditioning. | 1.56e-05 | 2 | 138 | 2 | 22117619 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30458172 | ||
| Pubmed | Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. | 1.56e-05 | 2 | 138 | 2 | 19142853 | |
| Interaction | ITGB3 interactions | 2.34e-06 | 170 | 136 | 9 | int:ITGB3 | |
| Cytoband | 1q23-q25 | 5.36e-05 | 4 | 138 | 2 | 1q23-q25 | |
| GeneFamily | Cyclin dependent kinases | 7.55e-06 | 26 | 89 | 4 | 496 | |
| GeneFamily | Ferlin family | 3.55e-04 | 6 | 89 | 2 | 828 | |
| GeneFamily | SPOUT methyltranferase domain containing | 6.58e-04 | 8 | 89 | 2 | 1294 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.43e-04 | 9 | 89 | 2 | 1230 | |
| GeneFamily | Laminin subunits | 1.53e-03 | 12 | 89 | 2 | 626 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.00e-03 | 181 | 89 | 5 | 694 | |
| GeneFamily | Dyneins, axonemal | 3.11e-03 | 17 | 89 | 2 | 536 | |
| Coexpression | LEIN_MEDULLA_MARKERS | 6.09e-06 | 86 | 137 | 6 | M1722 | |
| Coexpression | LEIN_MEDULLA_MARKERS | 7.93e-06 | 90 | 137 | 6 | MM719 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | CACNA2D1 ZBTB16 DDR2 LAMC1 TGFBR3 PIEZO2 AEBP1 NID1 MMP2 SDK1 | 5.96e-10 | 196 | 138 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | CACNA2D1 KIF26B DDR2 LAMC1 PIEZO2 AEBP1 NID1 MMP2 SDK1 CDH13 | 6.58e-10 | 198 | 138 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-09 | 179 | 138 | 9 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.06e-08 | 195 | 138 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.16e-08 | 197 | 138 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.63e-07 | 193 | 138 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-07 | 194 | 138 | 8 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-07 | 194 | 138 | 8 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-07 | 196 | 138 | 8 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-07 | 196 | 138 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-07 | 198 | 138 | 8 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.99e-07 | 198 | 138 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.99e-07 | 198 | 138 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.99e-07 | 198 | 138 | 8 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-07 | 199 | 138 | 8 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-07 | 200 | 138 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 174 | 138 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 180 | 138 | 7 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 180 | 138 | 7 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-06 | 183 | 138 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-06 | 186 | 138 | 7 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.10e-06 | 189 | 138 | 7 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 189 | 138 | 7 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-06 | 190 | 138 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-06 | 190 | 138 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.18e-06 | 190 | 138 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.18e-06 | 190 | 138 | 7 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-06 | 191 | 138 | 7 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-06 | 191 | 138 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-06 | 191 | 138 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-06 | 191 | 138 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.34e-06 | 192 | 138 | 7 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.34e-06 | 192 | 138 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-06 | 192 | 138 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 138 | 7 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 138 | 7 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.42e-06 | 193 | 138 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.42e-06 | 193 | 138 | 7 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-06 | 194 | 138 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-06 | 194 | 138 | 7 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-06 | 194 | 138 | 7 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 194 | 138 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 195 | 138 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 195 | 138 | 7 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.59e-06 | 195 | 138 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 195 | 138 | 7 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 195 | 138 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 196 | 138 | 7 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 196 | 138 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 196 | 138 | 7 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.77e-06 | 197 | 138 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-06 | 197 | 138 | 7 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-06 | 197 | 138 | 7 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 198 | 138 | 7 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.86e-06 | 198 | 138 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-06 | 198 | 138 | 7 | 4a4566f86c9365a41b4cfd1609eac09bd73b3f34 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.96e-06 | 199 | 138 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.96e-06 | 199 | 138 | 7 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-06 | 199 | 138 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-06 | 199 | 138 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.06e-06 | 200 | 138 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-06 | 200 | 138 | 7 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 138 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-06 | 200 | 138 | 7 | 87177c973e722ac7d9ee503b9cfacd84fc67865d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 138 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-06 | 200 | 138 | 7 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-06 | 200 | 138 | 7 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-06 | 142 | 138 | 6 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.42e-06 | 142 | 138 | 6 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.42e-06 | 142 | 138 | 6 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 160 | 138 | 6 | 6215ac6123a295f3c2f033786602a57b2e2e1177 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-05 | 166 | 138 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 168 | 138 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 170 | 138 | 6 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.57e-05 | 171 | 138 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-05 | 172 | 138 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-05 | 173 | 138 | 6 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-05 | 174 | 138 | 6 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 175 | 138 | 6 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-05 | 175 | 138 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.03e-05 | 179 | 138 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 180 | 138 | 6 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 181 | 138 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.23e-05 | 182 | 138 | 6 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 185 | 138 | 6 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.44e-05 | 185 | 138 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.44e-05 | 185 | 138 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.52e-05 | 186 | 138 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.52e-05 | 186 | 138 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 187 | 138 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 187 | 138 | 6 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| Drug | 3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide | 8.49e-07 | 4 | 137 | 3 | ctd:C559860 | |
| Drug | Excitatory Amino Acid Agonists | 1.52e-06 | 33 | 137 | 5 | ctd:D018690 | |
| Drug | farnesylthiosalicylic acid | 1.63e-06 | 15 | 137 | 4 | ctd:C093323 | |
| Drug | methanandamide | 6.93e-06 | 21 | 137 | 4 | ctd:C088155 | |
| Drug | chaetoglobosins | 7.33e-06 | 7 | 137 | 3 | ctd:C019290 | |
| Drug | N-vinyl-2-pyrrolidinone | 1.69e-05 | 26 | 137 | 4 | ctd:C042670 | |
| Drug | YM 529 | 1.74e-05 | 9 | 137 | 3 | ctd:C087958 | |
| Drug | triciribine | 2.48e-05 | 10 | 137 | 3 | ctd:C023764 | |
| Drug | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | 2.65e-05 | 29 | 137 | 4 | ctd:C568862 | |
| Drug | AC1O0B8G | 3.07e-05 | 262 | 137 | 9 | CID000091605 | |
| Drug | 2-aminoethoxydiphenyl borate | 3.33e-05 | 61 | 137 | 5 | ctd:C109986 | |
| Drug | parthenin | 3.39e-05 | 11 | 137 | 3 | ctd:C022097 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 1.98e-06 | 20 | 136 | 4 | DOID:2526 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | CALCOCO2 ERCC6 RBM10 ETFDH OBSCN LAMC1 STK32C FBXO30 CDKL5 BUB1B NID1 AKT1 KDM2A MMP2 | 4.81e-06 | 702 | 136 | 14 | C0009402 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.02e-06 | 152 | 136 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 2.14e-05 | 121 | 136 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | corpus callosum volume measurement | 1.02e-04 | 100 | 136 | 5 | EFO_0010299 | |
| Disease | Angelman Syndrome | 1.26e-04 | 4 | 136 | 2 | C0162635 | |
| Disease | Dupuytren Contracture | 1.47e-04 | 108 | 136 | 5 | EFO_0004229 | |
| Disease | Myasthenic Syndromes, Congenital | 1.81e-04 | 24 | 136 | 3 | C0751882 | |
| Disease | osteoarthritis, knee, total joint arthroplasty | 2.09e-04 | 5 | 136 | 2 | EFO_0004616, EFO_0010726 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.49e-04 | 66 | 136 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.58e-04 | 27 | 136 | 3 | DOID:0050861 (is_marker_for) | |
| Disease | response to gases and fumes exposure, forced expiratory volume | 3.13e-04 | 6 | 136 | 2 | EFO_0004314, EFO_0006994 | |
| Disease | Aortic Diseases | 3.13e-04 | 6 | 136 | 2 | C0003493 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 3.21e-04 | 29 | 136 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 3.55e-04 | 30 | 136 | 3 | C0029925 | |
| Disease | right ventricular ejection fraction measurement | 3.55e-04 | 30 | 136 | 3 | EFO_0021816 | |
| Disease | central nervous system cancer | 3.92e-04 | 31 | 136 | 3 | EFO_0000326 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 4.36e-04 | 7 | 136 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | gestational age | 4.59e-04 | 138 | 136 | 5 | EFO_0005112 | |
| Disease | hippocampal volume | 4.71e-04 | 297 | 136 | 7 | EFO_0005035 | |
| Disease | ascending aortic diameter | 4.90e-04 | 140 | 136 | 5 | EFO_0021787 | |
| Disease | 2-hydroxyphenylacetate measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0800131 | |
| Disease | Marfan Syndrome, Type I | 7.43e-04 | 9 | 136 | 2 | C4721845 | |
| Disease | Non-Small Cell Lung Carcinoma | 7.99e-04 | 156 | 136 | 5 | C0007131 | |
| Disease | colorectal cancer (is_marker_for) | 8.22e-04 | 157 | 136 | 5 | DOID:9256 (is_marker_for) | |
| Disease | left ventricular ejection fraction measurement | 8.35e-04 | 40 | 136 | 3 | EFO_0008373 | |
| Disease | hypertrophic cardiomyopathy | 8.81e-04 | 92 | 136 | 4 | EFO_0000538 | |
| Disease | Neurodevelopmental Disorders | 9.18e-04 | 93 | 136 | 4 | C1535926 | |
| Disease | Alzheimer disease, educational attainment | 1.03e-03 | 247 | 136 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | left ventricular systolic function measurement | 1.10e-03 | 44 | 136 | 3 | EFO_0008206 | |
| Disease | aortic measurement | 1.12e-03 | 251 | 136 | 6 | EFO_0020865 | |
| Disease | Marfan Syndrome | 1.13e-03 | 11 | 136 | 2 | C0024796 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 1.13e-03 | 11 | 136 | 2 | DOID:2870 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.13e-03 | 447 | 136 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | spontaneous preterm birth | 1.25e-03 | 101 | 136 | 4 | EFO_0006917 | |
| Disease | Lung Neoplasms | 1.47e-03 | 265 | 136 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.50e-03 | 266 | 136 | 6 | C0242379 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.51e-03 | 49 | 136 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | skin melanoma (is_marker_for) | 1.59e-03 | 13 | 136 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Metabolic Bone Disorder | 1.85e-03 | 14 | 136 | 2 | C0005944 | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 1.85e-03 | 14 | 136 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.85e-03 | 14 | 136 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Uveal Melanoma | 1.90e-03 | 53 | 136 | 3 | EFO_1000616 | |
| Disease | cortical thickness | DPP4 ZBTB16 LAMC1 LAMC3 SH3PXD2A WNT3A YLPM1 MTMR2 LRP4 EML1 PLEC KLHL8 TRIM36 | 1.95e-03 | 1113 | 136 | 13 | EFO_0004840 |
| Disease | ocular sarcoidosis | 2.07e-03 | 116 | 136 | 4 | EFO_0010723 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.13e-03 | 15 | 136 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Osteopenia | 2.13e-03 | 15 | 136 | 2 | C0029453 | |
| Disease | neuropsychological test | 2.24e-03 | 197 | 136 | 5 | EFO_0003926 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 2.43e-03 | 16 | 136 | 2 | C0751885 | |
| Disease | endometriosis (biomarker_via_orthology) | 2.43e-03 | 16 | 136 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | nervousness | 2.43e-03 | 16 | 136 | 2 | NCIT_C74532 | |
| Disease | urate measurement, spine bone mineral density | 2.46e-03 | 58 | 136 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.74e-03 | 17 | 136 | 2 | C0751883 | |
| Disease | erythritol measurement | 2.74e-03 | 17 | 136 | 2 | EFO_0021171 | |
| Disease | fish consumption measurement | 3.25e-03 | 64 | 136 | 3 | EFO_0010139 | |
| Disease | electrocardiography | 3.26e-03 | 530 | 136 | 8 | EFO_0004327 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 3.43e-03 | 19 | 136 | 2 | C0751884 | |
| Disease | Meningioma | 3.43e-03 | 19 | 136 | 2 | C0025286 | |
| Disease | diet measurement | GABRB3 DSCAM DPY19L1 KIF26B ACSS1 TEX15 RANBP17 TLL1 MTMR2 UBR3 SDK1 CDH13 | 3.43e-03 | 1049 | 136 | 12 | EFO_0008111 |
| Disease | ovarian neoplasm | 3.49e-03 | 134 | 136 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 3.78e-03 | 137 | 136 | 4 | C1140680 | |
| Disease | acetate measurement | 3.79e-03 | 20 | 136 | 2 | EFO_0010112 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.98e-03 | 139 | 136 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 4.07e-03 | 550 | 136 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | metabolite measurement | 4.53e-03 | 560 | 136 | 8 | EFO_0004725 | |
| Disease | Nasopharyngeal carcinoma | 4.59e-03 | 22 | 136 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEKRYYSDPRFLNLW | 111 | O60566 | |
| GEYIKTWRPRYFLLK | 16 | P31749 | |
| GEYIKTWRPRYFLLK | 16 | P31751 | |
| YEEYIRPLLQSWRSK | 666 | Q99424 | |
| PWSYFPKISIYLRDE | 351 | Q9Y5Z0 | |
| YPNAGRYWETVERLK | 366 | Q9NUB1 | |
| PYGSEEYLQLRSKSW | 61 | Q86TW2 | |
| TETYVRWSPKGTYLA | 336 | P55884 | |
| DRGYIYWRLLSTDPV | 521 | P63010 | |
| ITYRSWGRSLKYNPV | 441 | P07357 | |
| DYWRILNPGEYRVTA | 941 | Q8IUX7 | |
| YVWIEGTKDPSRNRY | 461 | Q9HD20 | |
| FRKSQELRVWPGYDY | 241 | Q08345 | |
| RLRAKYDTPYIIWRS | 381 | Q6IC98 | |
| YRTKLRGPSYIWTFR | 4481 | Q96DT5 | |
| QYKYETGLSDSRPLW | 1696 | Q5JWR5 | |
| DRGYIYWRLLSTDPV | 521 | Q10567 | |
| LWYRAPELLLGAKEY | 601 | P21127 | |
| TWARYPLAVTKYRES | 616 | P19801 | |
| TIRYSVYKDPAGWLN | 511 | P55290 | |
| VTEWYELRKAPSDLY | 221 | P07384 | |
| GRDWERYTAAVPYRL | 456 | Q9UBM7 | |
| PEDLWVSYLGRVYDL | 31 | Q6P9G0 | |
| GWNSSLPVYYIREER | 256 | Q8TBY9 | |
| WIYSASTLERGYPKP | 541 | P08253 | |
| YYIGKERRTWEESLL | 131 | P26715 | |
| RPRGQRDSSYYWEIE | 331 | P04049 | |
| VTNLKYWGRYEPVIS | 596 | Q9H2T7 | |
| LYWDGERRTYVPALE | 606 | P98175 | |
| IRTIDYRKGDSWAYI | 481 | Q96T37 | |
| SWDYTKPYLGRRDRG | 256 | Q8WVV9 | |
| PWSAVRVKEYGYTRL | 386 | Q6ZNF0 | |
| YRASIRGKKWYSSPL | 941 | P0DP91 | |
| RYYWERERKPKTEEF | 956 | Q6IE37 | |
| RWYRAPEIMLNSKGY | 191 | P28482 | |
| LQRYLKTREKGPGYW | 31 | Q8TEW8 | |
| SRPYKISESSKVYRW | 11 | Q8N4N3 | |
| RYRLAEPTEKEYDWL | 1281 | Q9NU22 | |
| IKRGKTRNYLYPIWS | 16 | Q9UMX2 | |
| YRAVTELGRPDAEYW | 76 | Q30154 | |
| PMYKINYSRDGTRWI | 116 | Q16832 | |
| EVRQGLKAYSSWPTY | 186 | O76003 | |
| SPESWYRKAYEESRA | 36 | Q2KJY2 | |
| ITSYVRPVKFWERDY | 1511 | Q96RV3 | |
| RYDPRSNKWDYVAAL | 526 | Q9P2G9 | |
| GLDYLPSRYHSWLRD | 76 | Q8N8M0 | |
| RDGASPSRIYTYQWR | 596 | P14543 | |
| DYRRERWRKPTYSDK | 281 | Q2TBE0 | |
| YYILEESWCVRRSKP | 611 | Q2PZI1 | |
| PFSRSYYWIGIRKIG | 81 | P14151 | |
| WKLYDPLLEYRRQGI | 206 | Q13614 | |
| PSYRITWTGKEDIIY | 181 | P27487 | |
| YWRDKRLAYSGIPLN | 91 | P28472 | |
| EGTPLTLYYSHWRKL | 611 | Q9Y3T9 | |
| VYKNRSPLRAREYVW | 406 | Q6ZMM2 | |
| RLKIYEEAWTKYPRG | 276 | Q9BXJ9 | |
| YSEQTDVLRKGYWPS | 386 | Q6P4A8 | |
| YPQIRWYKDGALLTT | 6136 | Q5VST9 | |
| PAGYYLKESRGSRRW | 106 | Q6P988 | |
| IYTPKGYLDQWATRA | 1181 | Q9BXP8 | |
| WYRAPELLVGDVKYG | 166 | Q92772 | |
| YTIYPRDKDKRWEGV | 46 | Q16134 | |
| YFEYKRDWDSIRLPG | 216 | Q96M11 | |
| WTRYYETPEEEREKL | 126 | Q9Y2K7 | |
| RADTLSLPWKDYVIY | 851 | Q9UFH2 | |
| YDVRRRPWYIQGAAS | 236 | P54289 | |
| DYVATRWYRSPELLV | 161 | Q00532 | |
| RWYRSPELLVGDTQY | 166 | Q00532 | |
| PGTRRYWIKETDSEY | 56 | Q8NEG2 | |
| RKGSPVAYSLPDWYI | 91 | Q8NEG2 | |
| EAIYKERWPDYVREL | 436 | Q9H2U1 | |
| HPVTTYKTGDYWRLL | 821 | O75976 | |
| KPAEPWYKETTYRRD | 86 | Q5SVJ3 | |
| IGIFRVGWKTTREYY | 56 | Q13137 | |
| VYDGSLIDWLPYSRI | 191 | Q68D91 | |
| LIDWLPYSRISDYVG | 196 | Q68D91 | |
| IDRGWRRSGKYVYKP | 51 | O95260 | |
| WTEAYIDAVRRNKYP | 11 | Q9H819 | |
| YRLLRYSPVKDAWDE | 461 | Q96G42 | |
| GYVRDETVRAAPYDW | 156 | P04180 | |
| AIYKRTREDGPWIPY | 161 | P11047 | |
| FDSVRQRLPKYYSWE | 136 | Q5JUW0 | |
| LPTKRLKLEWVYGYR | 216 | O00423 | |
| RWPVSYADRKSYENL | 96 | Q8TB52 | |
| YVATRWYRSPELLLG | 171 | O76039 | |
| PESVGYRIKYWRSDL | 1206 | Q7Z5N4 | |
| DPRTKAGLYWGYTVR | 251 | Q5T280 | |
| EVRIWSYTQPRYEKE | 241 | Q8NAC3 | |
| WARFYVKIYRAEGLP | 416 | Q9HC10 | |
| LRWYLATGEEIYDVP | 56 | O60469 | |
| PWARFYVRLYKAEGL | 241 | Q2WGJ9 | |
| REAWATKGPSYEDLY | 236 | P29083 | |
| WAFRVEPYSYLVKVG | 576 | Q9NQ86 | |
| EALGIRKPYIWEYSR | 411 | P07814 | |
| DKLLWQDSRYRPLYP | 271 | Q9BYD3 | |
| PCTYYLEPKRRWVTG | 56 | Q5SQN1 | |
| YIEVRDGYWRKSPLL | 406 | O43897 | |
| YEKRGGTYWALLRTL | 106 | Q96HP8 | |
| RRWPISYCRELKGYS | 231 | Q8NBX0 | |
| TWEESGLRYDKAYPG | 86 | Q9HC36 | |
| SVYWPAKRGITIYAD | 326 | Q587J7 | |
| PSYVLYRDRAEWADI | 61 | P49354 | |
| GTDLLPYLDWDYVRV | 51 | Q2M3G4 | |
| GSLYKRYPSLWRRLA | 41 | Q12824 | |
| SATSVYWYRERPGEV | 51 | Q99603 | |
| AEYNRYTWVTGREPL | 146 | Q9NRC1 | |
| YELLRGWRPYDIHSS | 286 | Q86UX6 | |
| LKRLYRAPIDWIEEY | 151 | Q9H553 | |
| LWYGTGRKPYNLDVT | 256 | O43916 | |
| TTYKDQPYLWARLDR | 66 | Q8N999 | |
| AVRYLKPDVTQTWRY | 216 | Q6URK8 | |
| KSYSPEALWRYLTAR | 876 | Q96JI7 | |
| WEKRTDPRGRFYYVD | 336 | O00308 | |
| EIPPDWRIEKTYLYL | 656 | Q05516 | |
| VEGLRRLSDYPEYMW | 156 | Q9NRZ7 | |
| KPGVYTRVTSYRNWI | 396 | Q86T26 | |
| IRYLGKEGWAPASYL | 306 | Q5TCZ1 | |
| RGQRPKEGAYYVWTV | 391 | Q8TB22 | |
| YRRYKSRDIWAKIPS | 166 | Q7Z6L1 | |
| AGSRWPELYLYSRAD | 206 | Q6P2H8 | |
| RSLWYATHYPTDERK | 386 | Q9H5I5 | |
| FVDVYGYIATPRVWK | 1211 | Q6ZS81 | |
| RTSPSEEYWRLYVLK | 261 | P48067 | |
| EYRRYTWVTGKEPLT | 166 | Q8TDW4 | |
| LRYYRESADPLGAWL | 1346 | Q15149 | |
| AVWQLYPGRKYRAAD | 86 | O95988 | |
| YPERGDTWREKRDYV | 1376 | P49750 | |
| YGEILYRWGLREKRA | 866 | Q6PJI9 | |
| RLYSIDSEYNPWRKL | 1496 | Q6ZT12 | |
| GWVETLRPRYTYFKV | 251 | P56704 | |
| RSLSRKFTDWAYGPV | 371 | Q8NET8 | |
| AYVKYNGSRPREEWE | 456 | Q9UL62 | |
| RYRSILQLVKPWYDE | 131 | O43692 | |
| QIRATEGAYPRLYWS | 41 | Q9NVR7 | |
| WYDETLYAELLGKPR | 1721 | Q9BXT5 | |
| WYSPGTREARKEYLE | 36 | Q16762 | |
| GSKDRTVRLWPLYNY | 1666 | Q562E7 | |
| GTRPRWSALDGVVYY | 506 | Q03167 | |
| DYRYTGSDVWTPIEK | 1156 | Q9H0D2 | |
| TSDRLYWYRQDPGKS | 46 | A0A0B4J263 | |
| SEVIYGRKRWFLYPP | 186 | Q96S16 | |
| AIYKRSRADGPWEPY | 146 | Q9Y6N6 | |
| WPNGLTLDYDTRRIY | 1516 | O75096 | |
| PDRKKRYTVVGNPYW | 501 | P53667 | |
| QERDVYLPAGKWRSY | 671 | Q6NSJ0 |